Actieve functies van Jean Jacques Mention
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Corporate Officer/Principal | - | - |
Loopbaan van Jean Jacques Mention
Eerdere bekende functies van Jean Jacques Mention
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| GENOWAY | Corporate Officer/Principal | 01-01-2019 | - |
Axenis SAS
 Axenis SAS BiotechnologyHealth Technology Part of genOway SA, Axenis SAS develops gene technology and products. The company is based in Paris, France. Axenis was acquired by genOway SA on September 04, 2018 for $0.23 million. | Corporate Officer/Principal | 01-01-2015 | - |
Statistieken
Internationaal
| Frankrijk | 4 |
Operationeel
| Corporate Officer/Principal | 3 |
Sectoraal
| Health Technology | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| OSE IMMUNOTHERAPEUTICS | Health Technology |
| GENOWAY | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Axenis SAS
Axenis SAS BiotechnologyHealth Technology Part of genOway SA, Axenis SAS develops gene technology and products. The company is based in Paris, France. Axenis was acquired by genOway SA on September 04, 2018 for $0.23 million. | Health Technology |
